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A significant proportion of individuals develop chronic, persistent and recurrent genital
tract infections with Chlamydia trachomatis, which has been attributed to the numerous
strategies that the bacterium uses to subvert host immune responses. Animal chlamydia
models have demonstrated that protective immune response is mediated by CD4+ Th1
cytokine responses. Herein, we demonstrate that early after infecting the male genital
tract, C. muridarum triggers the production of IL-10 by splenic and lymph node cells. In
addition, C. muridarum triggers IL-6 and TNFα secretion. Data obtained from in vitro and
in vivo experiments revealed B cells as the major IL-10 contributors. Indeed, purified
B cells produced high amounts of IL-10 and also exhibited enhanced expression of
inhibitory molecules such as CD39, PD-L1 and PD1 after C. muridarum stimulation.
In vitro experiments performed with sorted cell subsets revealed that Marginal Zone B
cells were the main IL-10 producers. In vitro and in vivo studies using TLR-deficient mice
indicated that TLR4 signaling pathway was essential for IL-10 production. In addition,
in vivo treatments to neutralize IL-10 or deplete B cells indicated that IL-10 and B cells
played a significant role in delaying bacterial clearance ability. Moreover, the latter was
confirmed by adoptive cell transfer experiments in which the absence of IL-10-producing
B cells conferred the host a greater capability to induce Th1 responses and clear the
infection. Interestingly, NOD mice, which were the least efficient in clearing the infection,
presented much more Marginal Zone B counts and also enhanced TLR4 expression on
Marginal Zone B cells when compared to B6 and BALB/c mice. Besides, treatment with
antibodies that selectively deplete Marginal Zone B cells rendered mice more capable
of inducing enhanced IFNγ responses and clearing the infection. Our findings suggest
that B cells play a detrimental role in C. muridarum infection and that activation by innate
receptors like TLR4 and IL-10 production by these cells could be used by Chlamydia
spp. as a strategy to modulate the immune response establishing chronic infections in
susceptible hosts.
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INTRODUCTION
Chlamydia trachomatis, an obligate intracellular pathogen, is
the most common cause of sexually transmitted bacterial
infections worldwide (1). Despite improved surveillance and
treatment initiatives, the incidence of C. trachomatis infection
has increased dramatically over the past 30 years in both
developed and developing countries (2). Approximately 75%
of C. trachomatis infections in women and up to 50% of
those in men are asymptomatic; thus, they often remain
undiagnosed and/or untreated facilitating the development of
chronic infections and the spread of the pathogen (1, 3).
Clinical manifestations of chlamydial infections in women
include urethritis, bartholinitis, cervicitis, and upper genital
tract infection (including endometritis, salpingo-oophoritis,
and pelvic inflammatory disease), which if left untreated can
lead to severe reproductive complications (3, 4). In men, C.
trachomatis infects urethra being amajor cause of male urethritis,
which usually constitutes an acute episode of an underlying
chronic silent infection affecting the prostate, seminal vesicles,
epididymis, and testis (5–7).
In both, female and male genital tract infections, Chlamydia
stimulates a complex array of host innate and adaptive immune
responses (6, 8–10). It has been demonstrated that innate
immune receptors such as TLR4, TLR2, and others mediate the
recognition of chlamydial molecular patterns. Innate immune
cells rapidly recognize and limit the infection, and ultimately
influence the outcome through the modulation of the adaptive
immune response (11). Existing literature clearly points out
CD4+ T cells, particularly Th1cells, as the major immune
effectors for bacterial clearance in the genital tract (12–14). In
addition, host regulatory pathways also become activated to limit
the magnitude of excessive immunopathology (15). Although
effector innate and adaptive immune responses are induced,
they often fail to clear the infection or prevent subsequent re-
infections (16). In fact, the specific adaptive immune response
often fails to prevent re-infections, which are very frequent
(3, 17). This has been attributed to several immunoevasion
strategies of C. trachomatis, such as decreased MHC class I
and CD1d expression in infected genital tract epithelial cells
(18, 19). Also, C. trachomatis interferes with the induction of
apoptosis protecting itself against the immune response (20), and
modulates host cytokine production skewing immune responses
(21). Noteworthy, Chlamydia induces the production of IL-10, a
potent cytokine that can facilitate pathogen survival by negatively
regulating both innate and adaptive host responses (22–24). In
this regard, we recently reported higher IL-10 production and
delayed bacterial clearance in NOD mice after male genital tract
infection (25). Multiple cell types are capable of producing IL-
10 during Chlamydia infection including activated macrophages,
dendritic cells, keratinocytes, T and B lymphocytes (24–27).
However, the contribution of IL-10 producing cells to modulate
the quality, magnitude and direction of the host immune
response in C. muridarum infection has been scarcely studied.
In the present report, comparing different mice strains and
different time points we demonstrate that splenic and prostate-
draining lymph node cells from infected mice produce high
amounts of IL-10 in response to C. muridarum stimulation
early after infection through the engagement of innate immune
receptors. In vitro experiments showed that purified B cells and
MZB were the main producers and suggest that IL-10 production




Chlamydia muridarumWeiss strain was kindly supplied by K. H.
Ramsey (USA) and propagated in LCCMK2 cells as previously
described (25, 28). Briefly, cells were grown in RPMI-1640
medium supplemented with 20µg/mL of gentamicin, 5% FBS, at
37◦C and 5% CO2. Cells infected with C. muridarum were grown
for 72 h in the presence of 1µg/mL of cycloheximide. Infected
cell monolayers were detached by scraping and disrupted by
sterile glass beads to lyse the host cells and release elementary
bodies (EBs). Cell debris was removed by centrifugation at 500
× g for 15min. Chlamydia EBs were purified in a sucrose
urografin gradient [bottom layer 50% (w/v) sucrose solution;
top layer, 30% (v/v) urografin in 30mM Tris–HCl buffer, pH
7.4]; centrifugating at 9,000 × g and 25◦C for 60min. After
one-wash step with 0.2µm filtered PBS (pH 7.4), purified EBs
were pelleted and resuspended in an isotonic sucrose-phosphate-
glutamate (SPG) buffer and aliquots were stored frozen at
−80◦C. Infectious titers of this suspension were determined by
titration on LLCMK2 cell monolayers. In brief, after 48 h of
incubation, infected cells were fixed with methanol 100% and
then air dried. Chlamydial inclusions were stained with FITC-
monoclonal antibodies against chlamydial LPS (Biomerieux,
Marcy l’Etoile, France) and analyzed by fluorescence microscopy.
Chlamydial LPS (cLPS) was kindly supplied by Dr. Adrian Eley
(UK). cLPS was extracted and further repurified as previously
described (29, 30).
Inoculation of Animals
Six to Eight week old male NOD, C57BL/6 (B6), BALB/c,
µMT, IL-10−/−, TLR2−/−, and TLR4−/− mice were purchased
from Jackson Laboratory and then bred and maintained under
specific pathogen free conditions in the vivarium of the CIBICI,
Universidad Nacional de Cordoba, Argentina. µMT, IL-10−/−,
TLR2−/−, and TLR4−/− mice were on B6 background. Animals
were maintained in a 16 h light, 8 h dark cycle, at 20 ± 2◦C, with
food and water ad libitum. All experiments were approved by
and conducted in accordance with guidelines of the Committee
for Animal Care and Use of the Facultad de Ciencias Químicas,
Universidad Nacional de Córdoba (Res. HCD 240/216), in strict
accordance with the recommendation of the Guide for the Care
and Use of Laboratory Animals of the NIH (NIH publication 86–
23). All efforts were made to minimize suffering and discomfort.
As previously described (25), mice were inoculated in the meatus
urethra with 1 × 108 EBs of C. muridarum in 20 µL of SPG.
For the inoculation, animals were anesthetized and put on their
backs, the prepuce was pulled back and the inoculum was placed
on the meatus urethra, simulating its natural infection path to the
genital tract. A control group of animals was sham infected with
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20 µL of SPG. This time point was considered day 0 of infection.
Animals from the infected and control groups were euthanized
at different days post-infection (dpi) according to the parameters
under study.
Detection of Chlamydia spp. by
Polymerase Chain Reaction (PCR)
Qualitative and quantitative detection of C. muridarum was
performed by conventional and real time PCR, respectively, by
the amplification of the C. muridarum omp1 gene (25, 28).
Male genital tract tissues from infected and control animals
were obtained at different times pi. Total DNA was extracted
from tissue samples using commercially available extraction
columns (AccuPrep R© Genomic DNA Extraction Kit, Bioneer,
Daejeon, Korea) following the specifications provided by the
manufacturer. The primers used for amplification of a 100-bp
fragment of the omp1 gene were: sense 5′-GCC GTT TTG GGT
TCT GCT T-3′ and antisense 5′-CGT CAA TCA TAA GGC
TTG GTT CA-3′. The primers used for amplification of a 185
bp fragment of the eef2 housekeeping gene were as follows: sense
5′-AAG CTG ATC GAG AAG CTG GA-3′ and antisense 5′-
CCC CTC GTA TAG CAG CTC AC-3′. Conventional PCR was
performed as previously described (25). A sample was considered
positive when amplification of the omp1 gene was detected.
Quantitative PCR was performed on a StepOneTM instrument
(Life technologies, Carlsbad, CA, USA) using SYBR R© Select
Master Mix (Life technologies). Each qPCR experiment was
performed at least in triplicate, in a final volume of 15 µL. Each
reaction contained 2 µL of DNA template and 1µM of each
primer (sense/antisense) of both genes (the omp1 target gene
and the eef2 housekeeping gene). A single initial denaturation
step of 15min at 95◦C was followed by 40 cycles of 15 s at
95◦C (denaturation), 30 s at 60◦C (annealing), and 30 s at 72◦C
(elongation). Negative and positive controls were included in
each run. After performing thermal cycling, qPCR amplification
data were analyzed using StepOne software (Applied Biosystems,
Foster City, CA, USA).
Spleen and Lymph Node Cell Cultures
Single mononuclear cell suspensions from spleen or prostate
draining lymph nodes of individual mice were obtained by Ficoll-
Paque PREMIUM 1.084 centrifugation gradients (GE Healthcare
Bio-Sciences AB, Uppsala, Sweden). Live cells were counted by
trypan blue exclusion, resuspended in RPMI 1640-GlutaMAX
(Life Technologies), supplemented with 0.1% gentamicin (50
mg/mL), 50mM 2-ME (Life Technologies), and 10% FBS and
incubated in the presence of heat inactivated C. muridarum EBs
for 48 h (multiplicity of infection, MOI 1000) or medium alone.
All cell combinations were cultured at density of 0.5 × 106
cell/ml per well and set up in triplicate. Plates were incubated
for 48 h at 37◦C in a water saturated 5% CO2 atmosphere.
After the incubations, cytokine concentration or frequency of
cytokine-producing cells were assayed using ELISA kits or by
flow cytometry, respectively.
Flow Cytometry
For cell surface staining, 106 cells were labeled with 50–100 µl
of a mix of mAbs at proper concentrations in PBS containing 3%
FCS for 20–30min at 6–8◦C in the dark. The following antibodies
were used: CD45, CD19, CD21, CD23, CD43, CD3, CD11b,
CD11c, pErk, pStat3, PD1, PD-L1, CD39, FcγRIIb, and TLR4
(Biolegend or eBioscience, San Diego, CA, USA). Staining with
the Fixable Viability Dye eFluor 780 (eBioscience) was performed
before cell surface staining, according to the manufacturer’s
instructions. Intracellular IL-10 expression was visualized by
immunofluorescence staining and analyzed by flow cytometry, as
described (31). Briefly, isolated leukocytes or purified cells were
resuspended (2× 106 cells/ml) in complete medium (RPMI 1640
media containing 10% FCS, 200 200 µ/ml penicillin, 200 U/ml
streptomycin, 4mM L-glutamine, and 0.05mM 2-ME; all from
Life Technologies) with LPS (10µg/ml, Escherichia coli serotype
0111: B4; Sigma-Aldrich), PMA (50 ng/ml; Sigma-Aldrich),
ionomycin (500 ng/ml; Sigma-Aldrich), and monensin (2µM;
eBioscience) for 5 h in 48-well flat-bottom plates. After cell
staining for surface molecules, cells were fixed and permeabilized
with CytofixCytoperm (BD Biosciences) and stained with anti-
mouse IL-10 mAb (Biolegend) according to the manufacturer’s
instructions. Data were collected on LSR II or FACS-CANTO
flow cytometers (BD Biosciences, San Jose, CA, USA) and
analyzed using FlowJo software (TreeStar Inc., Ashland, OR,
USA). Proper compensation using Fluorescence Minus One
(FMO) controls were used.
B Cell Purification and Culture
Single cell suspensions were obtained from spleen, stained with
anti-mouse B220 and CD19 fluorochrome-conjugated Abs and
then positively selected by CD19 and B220 expression using
a FACSAria Cell Sorter (BD Biosciences). To purify different
B subsets, sort gates were defined based on B220, CD19,
CD21, CD23, and CD4 expression: Follicular B (FOB) cells
(CD21intCD24int CD23+), marginal zone B (MZB)-like cells
(CD21hiCD24hiCD23−) and B1 cells (CD43+CD19+) (26, 32,
33). Sort purities were >97%. Following this procedure, purified
B cells (CD19+ B220+) or B cell sub-populations (FOB, MZB-
like and B1) were adjusted to a final concentration of 2 × 106
cells/ml and cultured with heat inactivated EBs of C. muridarum
for 48 h (multiplicity of infection, MOI 1000) or medium alone.
The contents of IL-10 and total immunoglobulins in culture
supernatants were measured by ELISA.
Cytokine Quantification
Cytokine concentrations in culture supernatants were
determined by ELISA using paired antibodies for murine
IL-10, IL-6, TNFα, IL-17A, and IFNγ (eBiosciences) according
to the manufacturer’s instructions.
Antibody Treatments
To neutralize IL-10 in vivo, mice were treated with an IgG1
antibody (clone JES5-2A5) as previously described (34). Mice
were i.p. injected (500 µg/mouse) 1 day prior to C. muridarum
inoculation and also on days 0, 2, and 4 pi.
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To deplete B cells, mice were treated with the IgG2a anti-
mouse CD20 Ab (clone 5D2, kindly provided by Genentech
Inc., San Francisco, CA, USA) as previously described (35).
The antibody was i.p. administered (50 µg/mouse, single
dose) 10 days prior to C. muridarum inoculation. Depletion
was confirmed by peripheral blood, spleen and lymph node
CD19+ B cells staining and flow cytometry analysis. Depletion
efficacy showed to be ≥90% in peripheral blood the day
before inoculation.
To deplete MZB cells, mice were treated with the IgG1 anti-
mouse Ly9.7.144 mAb as previously described (36). The antibody
was i.p. administered (250µg/mouse, single dose) 1 day before C.
muridarum inoculation. Depletion was confirmed by spleen cells
staining and flow cytometry analysis in infected and non-infected
mice as previously described (36).
Adoptive Transfer Experiments
Sorted splenic B cells (2 × 106 cells in total) from WT or IL-10
−/− mice were i.v. injected into IL-10 −/− mice 1 day before
C. muridarum inoculation. Mice were euthanized 7 days later.
Chlamydial DNA was analyzed in prostate tissue as previously
described (25).
Statistical Analysis
Statistical analysis was performed using one-way ANOVA with
Bonferroni post hoc test analysis. Data are shown as mean± SEM
in the graphs. Statistical tests were performed using the GraphPad
Prism 5.0 software (GraphPad Software Inc., La Jolla, CA, USA).
P-values ∗< 0.05, ∗∗< 0.01, and ∗∗∗< 0.001 were considered
significant in all analyses.
RESULTS
C. muridarum Induces the Secretion of
IL-10 by Mononuclear Cells Early
After Infection
Although there are data about different susceptibility in
Chlamydia female models of infection using strains such as B6,
BALB/c and others, there are almost no studies that analyze male
infection in different strains of mice. Previously, we described
that C. muridarum causes an ascending infection of the male
genital tract preferentially colonizing the prostate gland (25).
To analyze male genital infection and its relation with IL-10
production in different strains of mice we first analyzed bacterial
load in prostate tissue from infected mice of B6, BALB/c, and
NOD mice on different dpi. As shown in Figure 1A, B6 and
BALB/c mice showed significantly lower bacterial loads than
NOD mice at 30 dpi, indicating that they cleared the infection
more quickly and efficiently than NODmice.
The kinetics of IL-10 production was also analyzed at different
time-points after male genital tract infection with C. muridarum.
Spleen and prostate draining lymph node cells (dLNs) from
infected and non-infected animals were in vitro stimulated with
heat inactivated C. muridarum as previously reported (25) and
IL-10 concentration in culture supernatants was analyzed by
ELISA (Figures 1B–E). High levels of IL-10 were detected in
culture supernatants of mononuclear cells (either from spleen or
prostate draining lymph nodes) from infected NOD at early days
after infection, reaching peak levels at 4–7 dpi (Figures 1B,C).
Notably, splenic mononuclear cells produced much more IL-10
than prostate draining lymph node cells. Spleen mononuclear
cells from infected B6 and BALB/c mice also secreted IL-10 when
in vitro stimulated with heat inactivatedC. muridarum. However,
these values were significantly lower than those observed in cell
culture supernatants from NOD mice (Figure 1D). Although
increased secretion levels of IL-10 were also observed when
spleen mononuclear cells from non-infected NOD mice were
stimulated with heat inactivated C. muridarum, these levels
were much lower than those found when assaying spleen cells
from infected mice (compare values between Figures 1E,D).
Moreover, no significant differences in IL-10 levels were detected
in culture supernatants of spleen cells from non-infected B6
and BALB/c mice (Figure 1E). Also, increased levels of IL-
6 and TNFα secretion were detected in culture supernatants
of spleen cells from non-infected mice of all strains after
in vitro stimulation with heat inactivated C. muridarum, with no
differences between strains (Figures 1F,G).
Altogether, these results indicate that C. muridarum induces
IL-10, IL-6 and TNFα production by mononuclear cells.
Moreover, those mice that showed the highest capability to
secrete IL-10 (NOD mice) were the least efficient in clearing
the infection.
B Cells Are the Main Source of IL-10 After
C. muridarum Stimulation
To identify which immune cells produced IL-10 in response
to C. muridarum, we analyzed the phenotypic characteristics
of IL-10 producing cells both in vitro and in vivo. Our first
strategy was to in vitro stimulate spleen and dLNs mononuclear
cells from non-infected NOD, B6 and BALB/c mice and then
perform Abs staining for FACS analysis. Because preliminary
experiments yielded similar results in spleen and dLNs, and also
due to low cell numbers in dLN samples, we performed most of
the experiments with spleen mononuclear cells. Since all IL-10
producing cells were CD45+ (data not shown), we analyzed the
expression of IL-10 and CD19, CD3, CD11b, and CD11c within
CD45+ cells (Figure 2A). Mononuclear cells stimulated with
C. muridarum showed a higher frequency of IL-10 producing
cells than unstimulated cells (media). IL-10 producing cells
were mostly CD19+ cells although less frequencies of CD3+ or
CD11b+ cells were also detected (Figure 2A). On the contrary,
no IL-10 producing CD11c+ cells were observed (Figure 2A).
When comparing mice strains, higher frequencies of IL-10
producing cells were detected in C. muridarum stimulated
cells from NOD mice with respect to B6 and BALB/c mice
(Figure 2A). Remarkably, CD19+ cells were the major producers
of IL-10 in every mice strain analyzed. Taking into account that
these data come from experiments assaying mononuclear cells
from non-infected mice, results suggest that some C. muridarum
component is per se able to trigger IL-10 production, even if B
cells have not previously contacted chlamydial antigens.
We next monitored IL-10+CD19+ and IL-10+CD3+
cells at different time points after infection. In concordance
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FIGURE 1 | IL-10 production during C. muridarum infection of the male genital tract. (A) Quantitative PCR determination of chlamydial DNA (omp1 gene) in prostate
tissue from infected NOD, B6, and BALB/c mice. Mice were inoculated with C. muridarum and euthanized at different time points after infection as indicated in the
figure. Quantitative determination of chlamydial DNA (omp1 gene) was performed by real time PCR and the results are depicted as the relative expression to the eef2
housekeeping gene. (B–E) IL-10 levels measured by ELISA in culture supernatants of spleen (B) or prostate draining lymph node (C) cells from C. muridarum infected
NOD mice at different dpi. IL-10 was measured after in vitro stimulation with heat killed C. muridarum (black bars) or media (white bars). IL-10 in culture supernatants
of spleen cells from infected (D) or non-infected (E) NOD, B6, and BALB/c mice after heat killed C. muridarum stimulation (black bars) or media (white bars). IL-6
(F) and TNFα (G) measured by ELISA in culture supernatants from spleen mononuclear cells from non-infected NOD, B6, and BALB/c mice. Spleen and prostate
draining lymph node cells were in vitro cultured for 48 h with medium alone (media) or in presence of heat killed C. muridarum (Cm). Data are shown as mean ± SEM,
n ≥ 5 per group, and representative of 3 independent experiments with essentially the same results. Statistical analysis was performed using one-way ANOVA with
Bonferroni post hoc test analysis as appropriate. *p < 0.05, **p < 0.01 and ***p < 0.001.
with results described in Figure 1A, higher percentages
of IL-10+CD19+ cells from spleen were detected
in infected NOD mice during the first days of the
experimental schedule (Figure 2B). Moreover, no significant
changes in the IL-10+CD3+cell subset were observed
(Figure 2C).
To verify the results described above, different experiments
were performed. On the one hand, splenic CD19+ (purity>97%)
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FIGURE 2 | B cells are the main source of IL-10 secretion after C. muridarum stimulation. (A) Percentage of IL-10 producing cells among CD19+, CD3+, CD11b+,
and CD11c+ cells. Spleen mononuclear cells from non-infected NOD, B6, and BALB/c mice were in vitro stimulated with media or heat killed C. muridarum (Cm) for
48 h and IL-10+ cells were analyzed by flow cytometry. Since all IL-10 producing cells were CD45+, the analysis was performed gating CD45+ cells. Intracellular
IL-10 expression was visualized by immunofluorescence staining after a short incubation with PMA and inomycin as previously described (31). Proper compensation
using Fluorescence Minus One (FMO) controls were performed. Only viable cells were analyzed by the use of Fixable Viability Dye eFluor 780. (B) IL-10+CD19+ and
(C) IL-10+CD3+ cells from spleen of non-infected (mock) or infected NOD mice analyzed at different dpi. Spleen mononuclear cells were in vitro stimulated with heat
killed C. muridarum. Data are shown as mean ± SEM, n ≥ 5 per group, and representative of 3 independent experiments with essentially the same results.
Statistical analysis was performed using one-way ANOVA with Bonferroni post hoc test analysis as appropriate. *p < 0.05, **p < 0.01.
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and CD19− cells were sorted from non-infected NOD mice and
then in vitro stimulated with heat inactivated C. muridarum.
High levels of IL-10, accompanied by slightly detectable amounts
of IL-6 and TNF-α, were detected in culture supernatants from
stimulated CD19+ cells (Figure 3A). On the contrary, minimum
IL-10 production and significantly higher IL-6, TNF-α and INFγ
levels were detected in culture supernatants from C. muridarum
stimulated CD19− cells (Figure 3A). As IL-10 production by B
cells could be triggered through Toll-like receptor engagement
(36), we assessed IL-10 secretion after chlamydial LPS (cLPS)
stimulation of CD19+and CD19− cells. High contents of IL-10
were detected in culture supernatants from CD19+ cells, while
only high levels of TNF-α were detected in culture supernatants
from cLPS stimulated CD19− cells (Figure 3B).
On the other hand, and to confirm the participation of TLR-
4 in this process, the secretion of IL-10 by spleen mononuclear
cells of infected TLR4−/− and wild type (B6) mice was ex vivo
analyzed after C. muridarum stimulation. Markedly high levels of
IL-10 were secreted by mononuclear cells from infected wild type
mice (Figure 3C); however, this effect was completely abrogated
when cells lacked TLR4 expression, showing similar secretion
levels to those observed in mononuclear cells frommock infected
wild type mice (Figure 3C). In agreement, sorted CD19+ cells
from TLR4−/− mice exhibited a complete inability to secrete
IL-10 when they were in vitro stimulated with C. muridarum
(Figure 3D), indicating that B cells need TLR4 to produce IL-10
in response to C. muridarum. However, it should not be ruled
out the possible participation of TLR4 in the production of other
cytokines in addition to IL-10. Moreover, TLR2 signaling showed
to be partially involved since purified B cells from TLR2−/− mice
produced significantly higher amounts of IL-10 amounts when
stimulated with C. muridarum, although these levels were much
lower than those from cells from wild type mice (Figure 3D).
Altogether, these data indicate that B cells are the major source of
IL-10 and that bacterial components trigger its secretion through
the engagement of innate immune receptors.
MZB Cells Are the Main IL-10 Producers
In mice, three mature splenic B cell subsets with different
functional activities, phenotypes and/or topographic locations
have been identified so far: B1, FOB and MZB cells (37, 38).
Thus, as indicated in Figure 4A, spleen B cell subsets were sorted
according to the expression of characteristic surface markers
and then in vitro stimulated with C. muridarum as described
above. As shown in Figure 4A, high concentration of IL-10 was
detected in culture supernatants of MZB-like cells, whereas no
significant IL-10 amounts were detected in culture supernatants
of either FOB or B1 cells. Phenotype of IL-10 B subsets from
dLNs was not evaluated. To further analyze the phenotypic
characteristics of IL-10 producing cells we searched for the
expression of different molecules after C. muridarum stimulation
and found higher pSTAT3 and pERK immunostaining together
with enhanced surface expression of CD39, PD-L1, PD1 and
FcγRIIb in CD19+IL-10+ cells when compared to CD19+IL-
10− cells (Figure 4B). Altogether, these data indicate that in
vitro MZB-like cells are the major IL-10 contributors after C.
muridarum stimulation. Moreover, IL10-secreting B cells express
different molecules involved in immune regulation.
IL-10 Producing B Cells Delay
Bacterial Clearance
To gain understanding of the possible IL-10 and B cell
contribution to bacterial clearance in NOD mice, we performed
IL-10 blocking or B cell depletion in vivo experiments by
administering mice with anti-IL10-neutralizing or anti-CD20-
depleting antibodies, respectively (Figure 5A). B cell depletion
efficacy showed to be ≥90% in spleen from NOD mice
(Figure 5A). He administration of IL-10 blocking antibodies
during the first days of the experimental scheme resulted in
significantly lower prostate bacterial loads when compared with
untreated mice (Figure 5B). In addition, the anti-CD20 Ab
treatment resulted in even lower bacterial loads indicating that in
the presence of low bioavailable IL-10 or low B cell counts during
the first days of the experimental scheme, infected animals can
clear bacteria from prostate tissue more efficiently (Figure 5B).
To assess if this improvement in clearing the infection was
associated to the induction of enhanced Th1 immune responses,
we analyzed the levels of INFγ producing T cells. Indeed,
elevated frequencies of INFγ+ CD3? cells were detected in spleen
from αCD20 Ab treated mice (Figure 5C). Thus, anti CD20 Ab
treatment conferred NOD mice the capability of inducing more
robust Th1 responses and clearing the infection more efficiently.
A preferential C. muridarum colonization of the prostate is
also observed in B6 mice (25). In concordance with bacterial
loads observed in αIL10 or αCD20 treated NOD mice, B6
mice deficient in IL10 (IL10−/−) or B cells (µMT) exhibited
lower bacterial loads in prostate tissue than their wild type
(B6) counterparts (Figure 5D). In agreement, both IL-10−/− and
µMTmice showed higher frequencies of INFγ-producing T cells
in the spleen (Figure 5E). Finally, we performed adoptive transfer
experiments in which purified B cells from WT or IL10−/−
mice were transferred into IL-10−/− recipients (Figure 5F).
When IL-10−/− mice received B cells able to produce IL-10
(WT B cells), higher bacterial loads were detected in prostate
tissue (Figure 5G). However, IL-10−/− mice that received B cells
unable to produce IL10 (IL-10−/− B cells) showed similarly
reduced bacterial loads to those observed in infected IL-10−/−
mice (Figure 5G).
These data suggest that in the absence of B cells, bioactive IL-
10 or IL-10 producing B cells,C.muridarum clearance is achieved
more efficiently, a process concomitant to the generation of
robust Th1 immune responses.
MZB Cells Impair Bacterial
Clearance Ability
Previously, we observed a higher frequency of IL-10 producing
cells within MZB-like cell subpopulation (Figure 3A) and also
that NOD mice showed the highest frequency of IL-10+ cells
during the course of the infection (Figures 1B–D, 4A). We then
aimed to quantify the frequencies of MZB-like and FOB cells
in the spleen from NOD, B6, and BALB/c mice. As shown in
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FIGURE 3 | Purified B cells produce IL-10 through the engagement of innate immune receptors after C. muridarum stimulation. (A) Cytokine levels measured by
ELISA in culture supernatants from sorted purified spleen CD19+ or CD19− cells (purity >97%) after in vitro stimulation with C. muridarum (B) Cytokine levels
measured by ELISA in culture supernatants from purified spleen CD19+ or CD19− cells (purity >97%) after in vitro stimulation with chlamydial LPS (cLPS) (C) IL-10
levels measured by ELISA in culture supernatants of spleen mononuclear cells from C. muridarum-infected TLR4−/− and wild type (B6) mice at 4 dpi. (D) IL-10
production by spleen sorted CD19+ purified B cells from wild type (B6), TLR2−/− and TLR4−/− mice after in vitro stimulation with media or heat killed C. muridarum.
Data are shown as mean ± SEM, n ≥ 5 per group, and representative of 3 independent experiments with essentially the same results. Statistical analysis was
performed using one-way ANOVA with Bonferroni post hoc test analysis as appropriate. *p < 0.05, **p < 0.01 and ***p < 0.001.
Figure 6A, NOD mice showed significantly much more MZB-
like cell frequencies and counts than the other mice strains.
On the contrary, slight differences in FOB cell frequencies and
counts were found (Figures 6A,B). Since results shown above
suggested that IL-10 secretion by B cells was triggered through
the engagement of innate receptors by bacterial PAMPs, we
analyzed TLR4 expression in spleen B cells and no B cells and
showed higher TLR4 expression only in B cells from NOD mice,
while no differences were observed in no B cells between the
strains under study (Figures 6C,D). We also analyzed TLR4
expression in B cell subsets. Enhanced TLR4 expression was
observed in CD21hiCD23− MZB-like cells when compared
with CD21intCD23+ FOB cells in all mice strains under study
(Figure 6C). Besides having a higher frequency of CD21hiCD23−
MZB-like cells, the MZB-like cells from NOD mice exhibited
an increased TLR4 expression than MZB-like cells from B6 or
BALB/c mice (Figures 6E,F).
To assess the possible MZB cell implication in the delayed
bacterial clearance observed in NOD mice, we performed in
vivo experiments in which mice were treated with an anti-Ly9
antibody (Figure 7A), which has been reported to selectively
eliminate MZB cells (35). As can be seen in Figure 7B, anti-Ly9
treated mice showed a significant reduction inMZB cells whereas
minor changes were detected in the FOB compartment. When
IL-10 production was analyzed in culture supernatants of spleen
mononuclear cells from anti-Ly9 treated mice, significantly
diminished IL-10 levels were observed, suggesting that MZB
cells were important IL-10 contributors also in vivo (Figure 7C).
Interestingly, the administration of anti-Ly9 antibodies resulted
in significantly lower prostate bacterial loads and enhanced IFNγ
production when compared to untreated mice (Figures 7D,E).
These results suggest that the enhanced capacity to produce IL-
10 exhibited by NODmice is related to the presence of highMZB
cell counts, thus postulating MZB cells as an important source of
IL-10 secretion after C. muridarum stimulation.
DISCUSSION
IL-10 is a potent regulatory cytokine strongly implicated in
the modulation of Th1 responses (39, 40). Evidence of a role
for IL-10 in Chlamydia infections has been obtained from
studies in patients and animal models (22–24, 26, 27, 41,
42). Certainly, increased IL-10 levels have been reported in
endocervical secretions and semen from infected patients (39,
43, 44). Moreover, IL-10 gene polymorphisms associated with
high IL-10 producing ability has been proposed as risk factor
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FIGURE 4 | Marginal Zone B lymphocytes are the main IL-10 producers after C. muridarum stimulation. Spleen MZB, FOB, and B1 cell subsets were sorted according
to the expression of characteristic surface markers. (A) Representative staining of Marginal Zone (CD21hi, CD23−, CD19+), Follicular (CD21int, CD23+, CD19+), and
B1 (CD43+CD23+ CD19+) cell subsets from gated CD19+ B lymphocytes. Purified B subsets were in vitro cultured in presence of heat killed C. muridarum (black
bars) or media alone (white bars) for 48 h and IL-10 contents were measured by ELISA. (B) Representative gates from IL-10+CD19+ or IL-10−CD19+ cells from
NOD spleen mononuclear cells after in vitro stimulated with heat killed C. muridarum. Histograms showing the expression of pSTAT3, pERK, CD39, PD-L1, PD1, and
FcγRIIb in IL-10+ and IL-10−gated B cells. Data are shown as mean ± SEM, n ≥ 5 per group, and representative of 2 independent experiments with essentially the
same results. Statistical analysis was performed using one-way ANOVA with Bonferroni post hoc test analysis as appropriate. **p < 0.01.
for persistent infection (45). Animal models have also provided
compelling evidence of IL-10 production during C. muridarum
infection of the female genital tract (26, 27, 46). Studies
performed in mice deficient in IL-10, showed that the absence
of this cytokine skews the anti-chlamydial immune response
to a predominantly Th1 phenotype and prevented Chlamydia-
induced immunopathology (22, 45, 47). Thus, cumulative data
indicate that IL-10 has a critical role during Chlamydia infection
(23). However, it is still unclear whether one type or multiple
cell types actually provide that IL-10 rendering hosts less efficient
in clearing the infection. In the present report, we provide
compelling data indicating that an increased IL-10 production is
observed early after the infection of the male genital tract with
C. muridarum, being B cells the main source of that secretion.
Although it cannot rule out that other regulatory cytokines
could also be involved, our results demonstrate the regulatory
participation of IL-10 in the early stages of the infection. The
increased IL-10 productionmay skew the immune response away
from a Th1 pattern thus impairing efficient bacterial clearance
and favoring the establishment of chronic infections.
Evidence for a regulatory role of B cells was firstly described
in a mouse model of inflammatory bowel disease (48). After
that, several groups have reported that regulatory B cells play a
role in diverse autoimmune, allergic and infectious conditions
(49–53). The presence of IL-10 secreting B cells has been
reported after Schistosoma mansoni, Leishmania major, Brudia
pahahgi, Listeria monocytogenes, and other pathogen infection
models in mice (53–56). In these studies, IL-10 secreting B
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FIGURE 5 | IL-10-producing B cells contribute to delay bacterial clearance. (A) Experimental scheme showing mice treatments with neutralizing αIL-10 or depleting
αCD20 antibodies. Representative dot plots showing CD19+B220+ cell frequencies in spleen from untreated and αCD20 treated mice show depletion efficiency
>90% at day 0. Mice were inoculated with C. muridarum at 0 dpi and euthanized at 14 dpi. (B) Prostate bacterial load assessed by quantitative PCR determination of
chlamydial DNA (omp1 gene) in prostate tissue from αIL-10-, αCD20-treated or untreated wild type NOD mice. (C) Percentage of IFNγ-producing CD3 cells in spleen
cultures from non-infected (mock), infected or infected and treated NOD mice after in vitro stimulation with media (white bars) or heat inactivated C. muridarum (Cm,
black bars). (D) Prostate bacterial load assessed by quantitative PCR determination of chlamydial DNA (omp1 gene) in prostate tissue from infected wild type (B6)
mice, mice deficient in IL-10 (IL-10−/−) or deficient in B cells (µMT) euthanized at day 7 dpi. (E) Representative dot plots showing CD3+ IFNγ+ cell frequencies in
spleen mononuclear cell cultures from non-infected (mock) or infected mice after in-vitro stimulation with heat killed C. muridarum (gated CD3 cells). (F) Experimental
scheme of adoptive B cell transfer into IL-10−/− mice. (G) Prostate bacterial load assessed by quantitative PCR determination of chlamydial DNA (omp1 gene) in
prostate tissue from infected IL-10−/− mice that received wild type or IL-10-deficient B cells. Data are shown as mean ± SEM, n ≥ 5 per group, and representative of
3 independent experiments with essentially the same results. Statistical analysis was performed using one-way ANOVA with Bonferroni post hoc test analysis as
appropriate. *p < 0.05.
cells were shown to mediate regulation of immune responses
by inhibiting different immune cells such as neutrophils, NK
cells, dendritic cells and inflammatory T cells (52–55). Also,
IL-10 producing B cells have been reported in animal models
of C. muridarum infection of the female genital tract (26).
In detail, Moore-Connors et al. showed that after Chlamydia
intravaginal infection, spleen CD43+IL-10+ or CD43−IL-10+
B cell subsets are induced (26). Authors focused their work
on the characterization of both B cell populations and showed
that CD43+ IL-10-producing B cells were induced via TLR
signaling, while CD43− IL-10-producing B cells required BAFF-
mediated signals from dendritic cells for their differentiation and
activation (26). Herein, using a different setting, we provided
results that indicate the induction of IL-10-producing B cells
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FIGURE 6 | NOD mice have a higher frequency of MZB cells and also enhanced TLR4 expression. (A) Representative staining of Marginal Zone (CD21hi, CD23−) and
Follicular (CD21low, CD23+) cell subsets from gated CD19+ B lymphocytes from NOD, B6 and BALB/c mice. (B) Total numbers of MZB and FOB cells in spleen from
NOD, B6 and BALB/c mice. (C) Representative histograms showing TLR4 expression on splenic FOB, MZB, and non-B cells from NOD, B6, and BALB/c mice.
(D) TLR4 mean fluorescence intensity (MFI) on B cells and no B cells from NOD, B6 and BALB/c mice (E) Representative histograms showing TLR4 expression on
MZB cells from NOD, B6 and BALB/c mice. (F) TLR4 mean fluorescence intensity (MFI) on MZB cells from NOD, B6, and BALB/c mice. Data are shown as mean ±
SEM, n ≥ 5 per group, and representative of two independent experiments with essentially the same results. Statistical analysis was performed using one-way ANOVA
with Bonferroni post hoc test analysis as appropriate. *p < 0.05, **p < 0.01 and ***p < 0.001.
FIGURE 7 | Marginal Zone B lymphocytes contribute to delay bacterial clearance. (A) Experimental scheme showing mice treatments with αLy9 antibody in B6 mice.
Mice were inoculated with C. muridarum at 0 dpi and euthanized at 7 dpi. (B) Representative dot plots showing MZB cell depletion in αLy9-treated mice. (C) IL-10
levels measured by ELISA in culture supernatants of spleen mononuclear cells from C. muridarum-infected and αLy9-treated or untreated B6 mice at 4 dpi. Spleen
mononuclear cells were in vitro cultured for 48 h with medium alone (media) or in presence of heat killed C. muridarum (Cm). (D) Prostate bacterial load assessed by
quantitative PCR determination of chlamydial DNA (omp1 gene) in prostate tissue from αLy9-treated or untreated B6 mice. (E) IFNγ levels in culture supernatants of
spleen mononuclear cells from uninfected (control), infected or infected and αLy9-treated B6 mice after in vitro stimulation for 48 h with media (white bars) or heat
killed C. muridarum (Cm, black bars). Data are shown as mean ± SEM, n ≥ 5 per group, and representative of two independent experiments with essentially the same
results. Statistical analysis was performed using one-way ANOVA with Bonferroni post hoc test analysis as appropriate. *p < 0.05, ***p < 0.001.
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after Chlamydia infection of the male genital tract. Our data
show that B cells from NOD, B6 and BALB/c mice produce
IL-10 upon C muridarum stimulation. Interestingly, male NOD
mice, which exhibited the least efficient bacterial clearance ability
with respect to other mice strains, were the highest IL-10
producers. More importantly, in vivo IL-10 neutralization or B
cell depletion rendered NOD mice more efficient in clearing the
infection suggesting a link between IL-10 secreting B cells and
the establishment of chronic infections. The importance of IL-
10 and B cells during C muridarum infection of the male genital
tract was also indicated by the improved bacterial clearance
ability observed in IL-10-deficient and µMT mice. However,
caution should be taken when interpreting these data since IL-
10 is absent not only in B cells in the first case, and defects
in T cells, dendritic cells and innate immune system has been
demonstrated in the second case (57). Nonetheless, our results
strongly suggest that IL-10 producing B cells play an important
role in the modulation of both the innate and adaptive immune
response against C muridarum. Moreover, Su et al. also reported
the induction of prominent IFNγ responses in Chlamydia-
infected female µMT mice, although shedding of bacteria was
not significantly different with respect to wild type mice (58).
Our results also indicate that the TLR4 signaling pathway was
essential for IL-10 production by B cells, in agreement with
similar data reported in CD43+ B cells (26), where CD43+ IL-10-
producing B cells displayed innate type features and were readily
induced by Chlamydia via TLR signaling (26). In our work,
findings showing IL-10 producing B cells from non-infectedmice
supports this data, since some C. muridarum component, such as
cLPS, signaling via TLR4, could be triggering IL-10 production,
even if B cells have not previously contacted chlamydial antigens.
Moreover, evidence provided herein show that not only IL-
10 but also PD1, PD-L1, CD39, and FcγRIIb expression are
up-regulated on B cells after Chlamydia stimulation. Similarly,
it has been reported that Helicobacter felis-stimulated B cells
produce IL-10 and express the inhibitory PD1molecule (59). This
evidence strongly suggests that these inhibitory molecules could
be also exerting immune regulation in our experimental model
of infection, since they are well-known mediators of immune
regulatory mechanisms (59, 60). Certainly, compelling evidence
indicates that B regulatory cells regulate immunity not only
through cytokine production but also via surface molecules such
as CD39, CD73, and PD1 (40). In fact, a novel population of B
cells has been shown to regulate colitis in an IL-10-independent
manner but dependent on CD73 and CD39 (61).
Currently, available data indicate that there is no transcription
factor or phenotypic cell marker specific for regulatory B cells
(49). In mice, different subsets of IL-10-producing B cells
have been reported, including CD5+CD1dhi B cells, transitional
2 marginal-zone precursor (T2-MZP) cells, marginal zone B
(MZB) cells, Tim+ B cells, CD138+ plasma cells and plasmablasts
(49, 50, 62, 63). It has also been described that MZB cells rapidly
respond to thymus-independent antigens, such as bacterial LPS
(62). As CD5+ and MZB cells share many properties with
innate immune cells, they have been named innate-like B cells.
Interestingly, innate-like B cells produce high amounts of IgM
and exhibit a rapid ability to produce high amounts of IL-10
following innate activation, being MyD88 and TLR signaling
required for their regulatory activities (62).
In our experiments, IL-10-producing B cells induced
after C. muridarum stimulation exhibited innate-like B cell
characteristics since they were rapidly induced during the course
of the infection and depended on TLR4 signaling. Noteworthy,
our results show that NOD mice, which exhibited the highest
frequencies of IL-10-secreting B cells, had the most abundant
splenic MZB cell counts with enhanced TLR4 expression.
In accordance, higher numbers of IL-10+ B cells have been
described in NOD mice with respect to B6 mice (63, 64, 64).
Moreover, treatment with anti-Ly9 antibody that deplete the
MZB cell population rendered NOD mice more efficient in
inducing enhanced Th1 immune responses and clearing the
infection, thus supporting a regulatory role for this cell subset
in our model of Chlamydia infection of the male genital tract.
In agreement with our results, Moore-Connors et al. described
two populations of IL-10 producing B cells during C. muridarum
infection of the female genital tract, CD43+ and CD43− IL10+B
cells; the first one showing phenotypic characteristic of CD5+
and MZB cells (26). It could be speculated that those CD43+
cells, similar to the MZB cells in our settings, would be the
relevant ones for the establishment of chlamydial chronic
infections, since the anti-Ly9 antibody depleting therapy used in
our experiments led to the induction of enhanced Th1 responses
and improved bacterial clearance capability. However, the
putative contribution of other IL-10 producing cells from other
anatomical sites cannot be ruled out, since anti-Ly9 antibody
therapy produced a marked, but not complete decrease of
IL-10 levels.
Based on the anatomical location of MZB cells, they are one
of the very first cells that come into contact with blood-borne
pathogens and are therefore posed to mount the first line of
the host defense response. It is intriguing how MZB cells would
play a significant role in infections localized in the genital tract;
however, it is possible that bacterial components, like cLPS,
shedded to circulation would reach and activate splenic MZB
cells. It is well-known that antigens trapped in the marginal
zone activate MZB cells to rapidly become IgM secreting plasma
cells or antigen presenting cells. The latter refers to MZB
cells as inducers of effector adaptive immune responses against
pathogens. In fact, it has been postulated that MZB cells play a
protective role in Staphylococcus aureus and Borrelia burgdorferi
infections (65). However, MZB cells have also been ascribed with
a regulatory role of the immune response being the major source
of IL-10 in Listeria monocytogenes and Leishsmania donovani
infections (56, 66). Whereas, multiple cell types have been shown
to be capable of producing IL-10, our results indicate that innate-
like B cell are the most relevant IL-10 source after C muridarum
stimulation. Furthermore, our results showed that the presence of
IL-10-producing B cells is associated with decreased IFNγ T cell
responses and impaired bacterial clearance ability. These effects
would be probably mediated through the inhibitory effects of IL-
10 on IFNγ production by NK cells, CD4+ T cells and CD8+
T cells (67, 68). Our findings suggest that, as described for the
female tract infection, B cells also play a detrimental role in C.
muridarum infection of the male genital tract. Innate activation
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and IL-10 production by B cells could be used by Chlamydia spp.
as an immunoevasion strategy to establish chronic infections in
susceptible hosts.
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